News

Nature16d
Identification of potent biparatopic antibodies targeting FGF receptors in solid tumours
Translocations involving FGFR2 gene fusions ... He co-led the discovery of EGFR mutations in lung cancer, advancing targeted therapies. As former Global Head of Oncology at Novartis, he ...
ascopubs.org2d
Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study
Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial Patients received induction ...
ascopubs.org27d
Concurrent osimertinib plus gefitinib for first-line treatment of EGFR-mutated non-small cell lung cancer (NSCLC).
NEJ026: Final overall survival analysis of bevacizumab plus erlotinib treatment for NSCLC patients harboring activating EGFR-mutations. This is an ASCO Meeting Abstract from the 2020 ASCO Annual ...
The American Journal of Managed Care5d
Jill Feldman
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health ...
Medscape7d
Potential Impact of Prescribing Metformin According to eGFR Rather Than Serum Creatinine
Delphine S. Tuot; Feng Lin; Michael G. Shlipak; Vanessa Grubbs; Chi-yuan Hsu; Jerry Yee; Vahakn Shahinian; Rajiv Saran; Sharon Saydah; Desmond E. Williams; Neil R. Powe ...